+46 470 70 69 00

Board of directors

Lars Kvarnhem, Chairman

Lars Kvarnhem has more than 15 years of experience from management and business development within med-tech companies. He has previously been main owner and CEO for the med-tech company Anmedic AB as well as board member for Stille AB. Lars is educated at KTH Royal institute of Technology.

Year of birth: 1972
Chairman since: 2017
Shares: 1 149 425 (1  149 425) through Priego AB
Independent in relation to major shareholders

Other assignments: Chairman of: Swevet AB , Cardiolex Medical AB, Abilia Sverige Holding AB, Inpac AirContainer Holding AB and Arcoma Incentive AB.

 

Peter Benson, Board member

Peter Benson is a graduate from Lund University and has an MA in Economics from the University of California. Peter has previously served as a Partner and Head of Life Science Investments for Vaekstfonden. His experience includes senior positions with Inter Alia, Pharmacia and Pharmacia Hospital Care. Previous board appointments include Inter Alia Ortivus BioGaia AB, and CellaVision.

Year of birth: 1955
Member since: 2010
Shares: none
Independent in relation to major shareholders

Other assignments: Chairman of: Alligator Bioscience Ab and Ascelia AB. Board member of: Jollingham AB, Montela Aktiebolag, Opsona Therapeutics Ltd. and Sunstone Capital A/S.

 

Mats Thorén, Board member

Mats Thorén has extensive experience in the medical technology sector, including with Handelsbanken Capital Markets as an account executive for the health sector in Corporate Finance, as an analyst in the biotechnology and medical technology at Enskilda Securities as well as Partner at Catella Healthcare AB. Previous board appointments include inter alia C-Rad AB, Cellartis AB and MIP Technologies AB.

Year of birth: 1971
Member/deputy: 2012/2010
Shares: 666 100 directly and through Vixco Capital AB
Independent in relation to major shareholders

Other assignments: Board member of: Pulsetten AB, Vixco Capital AB, Arcoma Incentive AB and board substitute for Eggelbertus Holding AB.

 

Anders Dahlberg, Board member

Anders Dahlberg is Head of Business Development at Aleris Group, and former CEO of Aleris Omsorg. He has over 15 years experience as a Partner and management consultant in several industries. Anders is M.Sc. in Industrial Economics at Chalmers University of Technology.

Year of birth: 1976
Member since: 2018
Shares: none
Independent in relation to major shareholders

Other assignments: Head of business development, Aleris Group. Board member of: Human Care HC AB and Abilia AB.